ANDERMAN JONATHAN (Sr VP, Gen Counsel & Corp Sec) received a stock award from COMPASS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/5/2026ACC: 0001171843-26-000051
Officer· Sr VP, Gen Counsel & Corp Sec
Since Aug 2024
+870K
Net shares
Net buyer
$775.5K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
870K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+150K
Price / share
$5.17
Trade value
$775.50K
% of position
714.3%
1/2/2026
21K→171K
Total
Net shares
+150K
Net value
$775.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | A · Award | +150K | $5.17 | $775.50K | 714.3% | 21K | 171K |
| Total | +150K | $775.50K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
720K shares
Shares
+720K
Strike price
5.17
Held after
720K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock720K shares | 1/2/2026 | A · Award | +720K | 5.17 | — | 720K |